Pembrolizumab shows promise in pretreated metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with…
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...